A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Clinical trial NCT01225380 · COMPLETED
Trial details
- NCT number
- NCT01225380
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.